ONYCHO-MED- miconazole nitrate, terbinafine hcl 
Medhart Pharmaceuticals, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Onycho-Med

Thank you for choosing Onycho-Med by Medhart Pharmaceuticals, Inc.    

To the licensed medical professionals:

This convenience kit is for prescription compounding only”

Please make sure the kit contains the following components:

Active Ingredients:

One Miconazole Nitrate USP 2% solution in 10ml bottle fitted with a brush cap lid One bottle containing 250 mgs of Terbinafine Hcl USP powder

In-Active Ingredients:

Acetic Acid, Aqua, Benzyl Alcohol, DMSO, IPA 70%, Laureth-4, PEG-6, Tea Tree Oil

How supplied:

Onycho-Med is a prescription only convenience kit for compounding by a healthcare professional for topical application in management of onychomycosis. The package contains premeasured bottles of Miconazole Nitrate 2% solution * and Terbinafine Hcl USP 250 mg** to make a final volume of 10 ml solution of Miconazole Nitrate 2% and Terbinafine Hcl USP 2.5%.

Indication:

Prescribed for the management of onychomycosis

Mixing Instructions - Easy Two Step Process

•	Carefully pour the contents of the bottle labelled Miconazole Nitrate 2% into the bottle labelled Terbinafine Hcl powder 250mg

To the licensed medical professionals:

This convenience kit is for prescription compounding only”

Shake

The non-compounded kit has a shelf-life of two years, The final product once mixed will follow a 30 day expiration as per USP 795 BUD (Beyond Use Date) guidelines. Healthcare professionals please follow your local state board of pharmacy BUD guidelines as well. Please discard any unused components of the kit appropriately. Miconazole Nitrate 2% solution meets the requirements for total aerobic microbial count of no more than 100 cfu/gm, as well as for absence of the specified microorganisms Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella and Candida albicans.

Storage:

The convenience kit and the compounded product can be stored at room temperature between (15 – 30 0c) and after compounding should be discarded after 30 days as per USP 795 guidelines. Protect from light, protect from freezing.

Onycho-Med compounding kit components have a two-year expiration date ***

For External Use Only: Keep container tightly closed, keep out of reach of children, and avoid contact with eyes.

* This product is not manufactured by Valeant Pharma manufacturers of Fungoid tincture

** Certificate of Analysis on file

***Data and documentation on file

Users are encouraged to report adverse events to FDA MedWatch

1-800-FDA-1088 or at http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053074.htm

RX Only

Revised: April2019

Dear professionals we always value your feedback, please email at: suggestions@medhartpharma.com

Manufactured for:

Medhart Pharmaceuticals, Inc.

50 Eagle Rock Way, Suite C, Brentwood Ca 94513

Ph: 1-833-MEDHART (633-4278)

PRINCIPAL DISPLAY PANEL

NDC 71150-0786-10
Rx Only

Onycho-Med

(Terbinafine Hcl USP 2.5% and  Miconazole Nitrate 2%)
FOR PRESCRIPTION COMPOUNDING ONLY
Topical Antifungal Solution

PRINCIPAL DISPLAY PANEL
NDC 71150-0786-10
Rx Only
Onycho-Med
(Terbinafine Hcl USP 2.5% and Miconazole Nitrate 2%)
FOR PRESCRIPTION COMPOUNDING ONLY
Topical Antifungal Solution

ONYCHO-MED 
miconazole nitrate, terbinafine hcl kit
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:71150-786
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71150-786-101 in 1 BOX; Type 0: Not a Combination Product05/30/2019
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 125 BOTTLE 250 mL  in 10 
Part 21 BOTTLE, WITH APPLICATOR 10 mL
Part 1 of 2
TERBINAFINE HYDROCHLORIDE 
terbinafine hydrochloride solution
Product Information
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE HYDROCHLORIDE250 mg  in 10 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
110 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/30/2019
Part 2 of 2
MICONAZOLE NITRATE 
miconazole nitrate solution
Product Information
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MICONAZOLE NITRATE (UNII: VW4H1CYW1K) (MICONAZOLE - UNII:7NNO0D7S5M) MICONAZOLE NITRATE200 mg  in 10 mL
Inactive Ingredients
Ingredient NameStrength
RIBOPRINE (UNII: 8EU82FAZ5J)  
ACETIC ACID (UNII: Q40Q9N063P)  
WATER (UNII: 059QF0KO0R)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
DIMETHYL SULFOXIDE (UNII: YOW8V9698H)  
LAURETH-4 (UNII: 6HQ855798J)  
POLYETHYLENE GLYCOL 300 (UNII: 5655G9Y8AQ)  
TEA TREE OIL (UNII: VIF565UC2G)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
110 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/30/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/30/2019
Labeler - Medhart Pharmaceuticals, Inc. (080145788)

Revised: 1/2023
Document Id: f112e265-c813-288e-e053-2a95a90ac3d9
Set id: 62762454-6bc3-4743-b276-721ef653b59c
Version: 9
Effective Time: 20230116
 
Medhart Pharmaceuticals, Inc.